Safety and Effectiveness of Isavuconazole Treatment for Invasive Fungal Infections in Chinese Patients with Haematologic Diseases: A Case Series. [PDF]
Luo P +6 more
europepmc +1 more source
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways. [PDF]
Hetta HF +10 more
europepmc +1 more source
New Perspectives on Antimicrobial Agents: Rezafungin. [PDF]
Forrister NM, McCarty TP, Pappas PG.
europepmc +1 more source
Antimicrobial dosing considerations in critically ill patients with acute kidney injury: A review. [PDF]
Tee C, Ngai M, See KC.
europepmc +1 more source
Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit. [PDF]
Dermitzaki N +5 more
europepmc +1 more source
Impact of Biofilm Formation by Vaginal <i>Candida albicans</i> and <i>Candida glabrata</i> Isolates and Their Antifungal Resistance: A Comprehensive Study in Ecuadorian Women. [PDF]
Cedeño-Pinargote AC +6 more
europepmc +1 more source
Related searches:
Echinocandins in Ocular Therapeutics.
Journal of Ocular Pharmacology and Therapeutics, 2017Fungal infections of the eye, especially fungal keratitis and endophthalmitis, are major causes of concern and if left untreated could lead to vision loss. Currently, natamycin (polyene antifungal) is the only commercially available topical agent used for the treatment of ocular fungal infections.
A. Patil, S. Majumdar
semanticscholar +4 more sources
Echinocandins: The Expanding Antifungal Armamentarium
The echinocandins are large lipopeptide molecules that, since their discovery approximately 41 years ago, have emerged as important additions to the expanding armamentarium against invasive fungal diseases. Echinocandins exert in vitro and in vivo fungicidal action against most Candida species and fungistatic action against Aspergillus species. However,
Daniel Aguilar-Zapata +2 more
exaly +5 more sources

